By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



P.O. Box 12878

Research Triangle Park  North Carolina  27709  U.S.A.
Phone: 919-544-8600 Fax: 919-544-8697




Merck & Co.  Antifungals

Company News
Eight Data Presentations At ECCMID Showcase The Broad Applicability Of SCYNEXIS, Inc. (SCYX)’ Lead Anti-Infective Candidate SCY-078 4/25/2017 8:23:14 AM
SCYNEXIS, Inc. (SCYX) To Host A Conference Call To Discuss Lead Anti-Infective Candidate SCY-078 Data Presented At 27th ECCMID 4/21/2017 7:58:48 AM
SCYNEXIS, Inc. (SCYX) Delays Initiation Of New Clinical Studies Using The IV Formulation Of SCY-078 At FDA’s Request 3/3/2017 10:21:26 AM
SCYNEXIS, Inc. (SCYX) Release: Company Announces Appointment Of Industry Veteran Marion Mccourt To Its Board Of Directors 1/26/2017 7:28:20 AM
SCYNEXIS, Inc. (SCYX) Achieves New Development Milestones Reinforcing The Versatility Of SCY-078 In Treating Serious Fungal Infections 12/13/2016 7:59:46 AM
SCYNEXIS, Inc. (SCYX) Completes Two Additional Clinical Studies Further Supporting The Favorable Safety Profile Of SCY-078 10/25/2016 8:05:10 AM
Why SCYNEXIS, Inc. (SCYX) Is Making A Run 10/7/2016 7:33:22 AM
SCYNEXIS, Inc. (SCYX) Announces Complete Results From Two Phase II Studies Of Oral SCY-078 In Patients With Candida Spp. Infections And Closing Of A $15 Million Term Loan 10/6/2016 7:16:02 AM
SCYNEXIS, Inc. (SCYX) To Present At The Ladenburg Thalmann Healthcare Conference 9/20/2016 8:10:55 AM
SCYNEXIS, Inc. (SCYX) To Present At Upcoming Investor Conferences 8/31/2016 7:56:58 AM